Drugs that had never been tested, or whose tests revealed a failing product, were now due to be re-registered in countries around the world. Much of the raw data didnât match what the company had filed with regulators.from Moneycontrol Business News https://www.moneycontrol.com/news/business/howâ-ranbaxyâ-hurtled-towardsmeltdown_12741201.html
No comments:
Post a Comment